Search

everythinglearnresearchcommunity

for

Search:↓

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Pediatric systemic lupus erythematosus is a severe autoimmune disease in children requiring early diagnosis and comprehensive management.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

Early and aggressive treatment with individualized care plans is crucial for managing pediatric systemic lupus erythematosus.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Renal histology is crucial for diagnosing simultaneous SLE and IgG4RD.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Brodalumab is more effective than ustekinumab for treating psoriasis.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Oncology specialists are disappointed by the discontinuation of the effective lymphoma treatment Bexxar.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Denosumab may cause alopecia areata.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

Early detection and infection prevention are crucial for improving survival in pediatric lupus patients with aplastic anemia.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Living with lupus as both a patient and doctor improved understanding and care for others.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

A fungus ball in the lung can cause coughing up blood in SLE patients.

A woman with skin and joint issues progressed from one type of lupus to another, highlighting the need to recognize complex conditions.

Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.

Trans-esophageal echocardiography is crucial for accurately diagnosing heart issues in lupus patients.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.